Kaur Rimanpreet, Arora Naina, Rawat Suraj S, Keshri Anand K, Singh Gagandeep, Kumar Rajiv, Prasad Amit
School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India.
Dayanad Medical College and Hospital, Ludhiana, Punjab, India.
J Cell Biochem. 2023 Oct;124(10):1587-1602. doi: 10.1002/jcb.30467. Epub 2023 Sep 12.
Metacestode, the larva of Taenia solium, is the causative agent for neurocysticercosis (NCC), which causes epilepsy. The unavailability of a vaccine against human NCC is a major cause for its widespread prevalence across the globe. Therefore, the development of a reliable vaccine against NCC is the need of the hour. Employing a combination of proteomics and immunoinformatics, we endeavored to formulate a vaccine candidate. The immune reactive cyst fluid antigens of T. solium were identified by immune-blotting two-dimensional gels with NCC patient's sera, followed by Matrix-assisted laser desorption-ionization analysis. We performed a detailed proteomic study of these immune reactive proteins by utilizing immune-informatics tools, identified the nontoxic, nonallergic, B-cell epitopes, and collected epitopes with the least sequence homology with human and other Taenia species. These epitopes were joined through linkers to construct a multiepitope vaccine. Different physiochemical parameters such as molecular weight (23.82 kDa), instability (39.91), and aliphatic index (49.61) were calculated to ensure the stability of the linked peptides vaccine. The vaccine demonstrated stable interactions with different immune receptors like Toll-like receptor 4 and IgG confirming that it will effectively stimulate the host immune response. We anticipate that our designed B-cell linear epitope-based vaccine will show promising results in in vitro and in vivo assays. This study provides a platform that would be useful to develop other suitable vaccine candidates to prevent helminthic neglected tropical diseases in near future.
猪带绦虫的幼虫——囊尾蚴,是神经囊尾蚴病(NCC)的病原体,可引发癫痫。缺乏针对人类NCC的疫苗是其在全球广泛流行的主要原因。因此,开发一种可靠的抗NCC疫苗迫在眉睫。我们结合蛋白质组学和免疫信息学,致力于设计一种候选疫苗。通过用NCC患者血清对二维凝胶进行免疫印迹,随后进行基质辅助激光解吸电离分析,鉴定了猪带绦虫的免疫反应性囊液抗原。我们利用免疫信息学工具对这些免疫反应性蛋白进行了详细的蛋白质组学研究,确定了无毒、无过敏反应的B细胞表位,并收集了与人类及其他绦虫物种序列同源性最低的表位。这些表位通过连接子连接,构建了一种多表位疫苗。计算了不同的理化参数,如分子量(23.82 kDa)、不稳定性(39.91)和脂肪族指数(49.61),以确保连接肽疫苗的稳定性。该疫苗与Toll样受体4和IgG等不同免疫受体表现出稳定的相互作用,证实它将有效刺激宿主免疫反应。我们预计,我们设计的基于B细胞线性表位的疫苗在体外和体内试验中将显示出有前景的结果。这项研究提供了一个平台,在不久的将来,该平台将有助于开发其他合适的候选疫苗,以预防被忽视的热带蠕虫病。